Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. | Vanderbilt Center for Clinical Cardiovascular Outcomes Research and Trials Evaluation

Koethe JR, Jenkins CA, Lau B, Shepherd BE, Silverberg MJ, Brown TT, Blashill AJ, Anema A, Willig A, Stinnette S, Napravnik S, Gill J, Crane HM, Sterling TR. Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010. HIV medicine. 2015 Oct;16(16). 572-7. PMID: 25960080 [PubMed] PMCID: PMC4558259 NIHMSID: NIHMS677949.

Abstract

Adipose tissue affects several aspects of the cellular immune system, but prior epidemiological studies have differed on whether a higher body mass index (BMI) promotes CD4 T-cell recovery on antiretroviral therapy (ART). The objective of this analysis was to assess the relationship between BMI at ART initiation and early changes in CD4 T-cell count.